Literature DB >> 7684054

Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain.

W R Gammon1, D F Murrell, M W Jenison, K M Padilla, P S Prisayanh, D A Jones, R A Briggaman, S W Hunt.   

Abstract

Autoantibodies to type VII collagen are characteristic of the blistering diseases epidermolysis bullosa acquisita and bullous systemic lupus erythematosus (SLE). Blisters in those diseases are due to defective adhesion of the lamina densa subregion of the epithelial basement membrane to the underlying dermis. Previous studies indicating that type VII collagen contributes to lamina densa-dermal adhesion by cross-linking lamina densa and dermal matrix proteins suggests that autoantibodies may contribute to blisters by interfering with type VII collagen function. That hypothesis is supported by previous studies showing autoantibodies from a small number of epidermolysis bullosa acquisita patients recognize proteolytic fragments containing the 145-kD noncollagenous domain of type VII collagen. In this study, we examined reactivity of autoantibodies from a large number of epidermolysis bullosa acquisita and bullous SLE patients with fusion proteins representing most of the noncollagenous domain of type VII collagen and that those regions are homologous to type III repeats of fibronectin. These results suggest autoantibodies binding to fibronectin homology regions within the 145-kD noncollagenous domain may interfere with the adhesion function of type VII collagen and contribute to lamina densa-dermal dysadhesion in epidermolysis bullous acquisita and bullous SLE.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684054     DOI: 10.1111/1523-1747.ep12472291

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

1.  [Vesicle, light hypersensitivity, mouth ulceration and arthralgia in a 40-year-old patient. Bullous systemic lupus erythematosus].

Authors:  A Kolb-Mäurer; S Herzog; C Sitaru; C Kneitz; D Zillikens; M Goebeler
Journal:  Hautarzt       Date:  2002-03       Impact factor: 0.751

Review 2.  Epidermolysis bullosa acquisita.

Authors:  Rishu Gupta; David T Woodley; Mei Chen
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

Review 3.  Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen.

Authors:  Mei Chen; Gene H Kim; Lori Prakash; David T Woodley
Journal:  Autoimmunity       Date:  2011-09-28       Impact factor: 2.815

Review 4.  Complement and cutaneous autoimmune blistering diseases.

Authors:  Elizabeth Lessey; Ning Li; Luis Diaz; Zhi Liu
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

5.  Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters.

Authors:  Artem Vorobyev; Hideyuki Ujiie; Andreas Recke; Jacqueline J A Buijsrogge; Marcel F Jonkman; Hendri H Pas; Hiroaki Iwata; Takashi Hashimoto; Soo-Chan Kim; Jong Hoon Kim; Richard Groves; Unni Samavedam; Yask Gupta; Enno Schmidt; Detlef Zillikens; Hiroshi Shimizu; Ralf J Ludwig
Journal:  J Invest Dermatol       Date:  2015-02-17       Impact factor: 8.551

6.  Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.

Authors:  Cassian Sitaru; Sidonia Mihai; Christoph Otto; Mircea T Chiriac; Ingrid Hausser; Barbara Dotterweich; Hitoshi Saito; Christian Rose; Akira Ishiko; Detlef Zillikens
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

7.  Detection of Type VII Collagen Autoantibodies Before the Onset of Bullous Systemic Lupus Erythematosus.

Authors:  Daniel A Grabell; Loderick A Matthews; Kim B Yancey; Benjamin F Chong
Journal:  JAMA Dermatol       Date:  2015-05       Impact factor: 10.282

8.  Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin.

Authors:  Cassian Sitaru; Arno Kromminga; Takashi Hashimoto; Eva B Bröcker; Detlef Zillikens
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

9.  Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.

Authors:  Jennifer Remington; Xinyi Wang; Yingpin Hou; Hui Zhou; Julie Burnett; Trevor Muirhead; Jouni Uitto; Douglas R Keene; David T Woodley; Mei Chen
Journal:  Mol Ther       Date:  2008-11-18       Impact factor: 11.454

10.  The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita.

Authors:  Mei Chen; Arvin Doostan; Pubali Bandyopadhyay; Jennifer Remington; Xinyi Wang; Yingping Hou; Ziu Liu; David T Woodley
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.